卡培他滨维持治疗晚期乳腺癌的临床观察_李剑英.pdfVIP

381381 P DOI: 10.3969/j.issn.1007-3969.2014.05.010 R737.9A1007-3639(2014)05-0381-06 Clinical observation of capecitabine in the maintenance treatment of advanced breast cancer LI Jian- ying, JI Cong-fei, CHEN Jia, TAN Qing-he (Department of Oncology, Nantong Tumor Hospital, Nantong Jiangsu 226361, China) Correspondence to: TAN Qing-he E-mail: tanqinghe@csco.org.cn AbstractBackground and purpose: Capecitabine, which is widely used in the first-line treatment of advanced breast cancer, was known little in the maintenance treatment of advanced breast cancer. The present study aimed to explore the efficacy and safety of capecitabine in the maintenance treatment of advanced breast cancer Methods: A total of 62 advanced breast cancer patients confirmed by histopathology and/or cytologywho had been evaluated as CR/PR/SD after first-line treatmen